Arrowstreet Capital, Limited Partnership Protalix Bio Therapeutics, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$3.58 - $6.45 $83,603 - $150,626	-23,353 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$3.15 - $3.98 $70,875 - $89,550	-22,500 Reduced 49.07%	23,353 $85,000
Q3 2020 Nov 12, 2020	BUY	$3.37 - $3.93 $37,744 - $44,016	11,200 Added 32.32%	45,853 $177,000
Q2 2020 Aug 12, 2020	BUY	$2.19 - $4.5 $75,890 - $155,938	34,653 New	34,653 $131,000

9.25M

40.6K

10.1K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $57.7M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.